NOVA BIOMEDICAL CORP

NOVA BIOMEDICAL CORP specializes in the manufacturing, supply, and maintenance of precision diagnostic instruments and consumables for federal healthcare and forensic laboratories. Their core capabilities center on analytical laboratory instrumentation, particularly glucose monitoring systems, in-vitro diagnostic reagents, and associated test strips, meters, and calibration components. The company provides end-to-end support for clinical diagnostics, including warranty services, equipment repair, and integration of automated sampling systems with bioreactor platforms. Technical expertise spans electrochemical sensor design, FDA-regulated medical device manufacturing, and compliance with CLIA and ISO 13485 standards for diagnostic quality systems. A key differentiator is their ability to deliver mission-critical consumables and maintenance services under tight federal timelines, ensuring uninterrupted operation of point-of-care and lab-based analyzers in high-stakes environments. NOVA BIOMEDICAL CORP maintains strong, recurring relationships with the Department of Health and Human Services, the Department of Veterans Affairs, and the Department of Justice, primarily supplying diagnostic test kits, glucose monitoring systems, and repair services for forensic and clinical labs. The Department of State and Department of Defense rely on them for medical supply chain continuity, particularly in overseas and field-deployed settings. Their contract patterns reflect long-term operational partnerships rather than one-time procurements, indicating trusted vendor status for mission-critical diagnostic infrastructure. The company’s primary industry focus is in analytical laboratory instrument manufacturing and in-vitro diagnostic substance production, serving the federal biomedical research, forensic toxicology, and veterans’ healthcare markets. They are positioned as a specialized supplier of validated, high-reliability diagnostic components rather than broad medical equipment distributors, with deep expertise in glucose monitoring technology and lab automation interfaces. As a small business structured as a 2L entity based in Waltham, Massachusetts, NOVA BIOMEDICAL CORP operates without federal certifications but leverages its technical precision and regulatory compliance rigor to serve sensitive government missions. Their geographic proximity to Boston’s biotech corridor enhances access to specialized talent and supply chain partners.